Drug comparisons
Sotagliflozin vs Vildagliptin
Compare Sotagliflozin (Inpefa) and Vildagliptin for type 2 diabetes. Sotagliflozin is a dual SGLT1/SGLT2 inhibitor with heart benefits, Vildagliptin is a DPP-4 inhibitor.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes and heart failure often compare Sotagliflozin and Vildagliptin for treatment selection.
Bottom line
The better drug between Sotagliflozin and Vildagliptin depends on your specific health needs and medical history.
All medication comparisons